GAFFI is addressing fungal diagnostic gaps by raising awareness, implementing models, and advocating for resource shifts, despite challenges in funding, infrastructure, and political support.
David W Denning, FRCP, FRCPath, FMedSci
Advertisement
Professor of Infectious Disease at The University of Manchester.
Articles by David W Denning, FRCP, FRCPath, FMedSci
The impact of the "95-95 by 2025" campaign and successes in countries like Uzbekistan and Guatemala, where action to improve diagnostic tools has addressed fungal infection challenges.
David W Denning, FRCP, FRCPath, FMedSci, outlines the "95-95 by 2025" initiative to diagnose and treat 95% of serious fungal infections globally by 2025, focused on improving access in underserved regions.
Advertisement
Latest Updated Articles
Fungal Infection Diagnosis, Misdiagnoses, and Global Health InitiativesPublished: January 27th 2025 | Updated:
Fungal Infections: Invisible Until It’s Too LatePublished: January 24th 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
2
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
3
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
4
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
5
